Results 251 to 260 of about 24,478 (263)

Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

Clinical Infectious Diseases, 2019
Bart Jan Kullberg, Luis L Ostrosky-Zeichner, Coleman Rotstein   +2 more
exaly  

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

Antimicrobial Agents and Chemotherapy, 2013
Eric Dannaoui
exaly  

The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase

Nature Communications, 2016
Annabel Braem, Jef Vleugels, Paul M Tulkens   +2 more
exaly  

Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin

Antimicrobial Agents and Chemotherapy, 2013
Louise A Walker, Neil A R Gow, Carol Anne Munro   +2 more
exaly  

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

Clinical Infectious Diseases, 2014
Shmuel Shoham, Annette Reboli, Juan Pablo Caeiro   +2 more
exaly  

A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis

Clinical Infectious Diseases, 2009
Marcio Nucci, Flavio Queiroz-Telles, Raoul Herbrecht   +2 more
exaly  

Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis

New England Journal of Medicine, 2002
Coleman Rotstein, Arnaldo Lopes Colombo
exaly  

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

Cancer, 2003
Ray Hachem, Russell E. Lewis
exaly  

Caspofungin for the Treatment of Pediatric Fungal Infections

Pediatric Infectious Disease Journal, 2008
Brian T. Fisher, Theoklis E. Zaoutis
openaire   +3 more sources

Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study

Natural Product Reports, 2014
exaly